These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7850009)

  • 21. Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men.
    Arwert LI; Roos JC; Lips P; Twisk JW; Manoliu RA; Drent ML
    Clin Endocrinol (Oxf); 2005 Sep; 63(3):310-6. PubMed ID: 16117819
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis.
    Antoniazzi F; Bertoldo F; Mottes M; Valli M; Sirpresi S; Zamboni G; Valentini R; Tató L
    J Pediatr; 1996 Sep; 129(3):432-9. PubMed ID: 8804334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced bone mineral density in adults with growth hormone (GH) deficiency: increased bone turnover during 12 months of GH substitution therapy.
    Degerblad M; Bengtsson BA; Bramnert M; Johnell O; Manhem P; Rosén T; Thorén M
    Eur J Endocrinol; 1995 Aug; 133(2):180-8. PubMed ID: 7655642
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults.
    Rodríguez-Arnao J; James I; Jabbar A; Trainer PJ; Perrett D; Besser GM; Ross RJ
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):455-62. PubMed ID: 9640412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study.
    Hansen TB; Brixen K; Vahl N; Jørgensen JO; Christiansen JS; Mosekilde L; Hagen C
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3352-9. PubMed ID: 8784096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bone mineral density in patients with growth hormone deficiency: does a gender difference exist?
    Hitz MF; Jensen JE; Eskildsen PC
    Clin Endocrinol (Oxf); 2006 Dec; 65(6):783-91. PubMed ID: 17121531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term maintenance of the anabolic effects of GH on the skeleton in successfully treated patients with acromegaly.
    Biermasz NR; Hamdy NA; Pereira AM; Romijn JA; Roelfsema F
    Eur J Endocrinol; 2005 Jan; 152(1):53-60. PubMed ID: 15762187
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The effect of growth hormone replacement therapy on markers of bone formation and bone mineral density in elderly men].
    Kozakowski J; Papierska L; Krassowski J; Zgliczyński S
    Pol Arch Med Wewn; 1998 Oct; 100(4):306-12. PubMed ID: 10335039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GH-deficient adults.
    Hubina E; Lakatos P; Kovács L; Szabolcs I; Rácz K; Tóth M; Szucs N; Góth MI
    Calcif Tissue Int; 2004 Jan; 74(1):55-9. PubMed ID: 14508626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endogenous sex steroid, GH and IGF-I levels in normal elderly men: relationships with bone mineral density and markers of bone turnover.
    Gürlek A; Gedik O
    J Endocrinol Invest; 2001 Jun; 24(6):408-14. PubMed ID: 11434664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term treatment with growth hormone stimulates osteoblastic and osteoclastic activity in osteopenic postmenopausal women: a dose response study.
    Brixen K; Kassem M; Nielsen HK; Loft AG; Flyvbjerg A; Mosekilde L
    J Bone Miner Res; 1995 Dec; 10(12):1865-74. PubMed ID: 8619366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
    Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
    J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Different responses of bone alkaline phosphatase isoforms during recombinant insulin-like growth factor-I (IGF-I) and during growth hormone therapy in adults with growth hormone deficiency.
    Magnusson P; Degerblad M; Sääf M; Larsson L; Thorén M
    J Bone Miner Res; 1997 Feb; 12(2):210-20. PubMed ID: 9041052
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth hormone (GH) treatment increases serum insulin-like growth factor binding protein-3, bone isoenzyme alkaline phosphatase and forearm bone mineral content in young adults with GH deficiency of childhood onset.
    Juul A; Pedersen SA; Sørensen S; Winkler K; Jørgensen JO; Christiansen JS; Skakkebaek NE
    Eur J Endocrinol; 1994 Jul; 131(1):41-9. PubMed ID: 7518728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of post-menopausal osteoporosis with recombinant human growth hormone and salmon calcitonin: a placebo controlled study.
    Gonnelli S; Cepollaro C; Montomoli M; Gennari L; Montagnani A; Palmieri R; Gennari C
    Clin Endocrinol (Oxf); 1997 Jan; 46(1):55-61. PubMed ID: 9059558
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of recombinant human growth hormone in elderly osteoporotic women.
    Sugimoto T; Nakaoka D; Nasu M; Kanzawa M; Sugishita T; Chihara K
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):715-24. PubMed ID: 10619976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of recombinant insulin-like growth factor-I and growth hormone on bone turnover in elderly women.
    Ghiron LJ; Thompson JL; Holloway L; Hintz RL; Butterfield GE; Hoffman AR; Marcus R
    J Bone Miner Res; 1995 Dec; 10(12):1844-52. PubMed ID: 8619364
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.